Compare · CELZ vs SPGI
CELZ vs SPGI
Side-by-side comparison of Creative Medical Technology Holdings Inc. (CELZ) and S&P Global Inc. (SPGI): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both CELZ and SPGI operate in Finance: Consumer Services (Finance), so they compete in similar markets.
- SPGI is the larger of the two at $126.21B, about 32852.6x CELZ ($3.8M).
- Over the past year, CELZ is down 71.5% and SPGI is down 19.8% - SPGI leads by 51.7 points.
- SPGI has been more active in the news (23 items in the past 4 weeks vs 7 for CELZ).
- SPGI has more recent analyst coverage (25 ratings vs 1 for CELZ).
- Company
- Creative Medical Technology Holdings Inc.
- S&P Global Inc.
- Price
- $0.81-0.47%
- $426.29+1.45%
- Market cap
- $3.8M
- $126.21B
- 1M return
- -59.90%
- +5.87%
- 1Y return
- -71.48%
- -19.80%
- Industry
- Finance: Consumer Services
- Finance: Consumer Services
- Exchange
- NASDAQ
- NYSE
- IPO
- News (4w)
- 7
- 23
- Recent ratings
- 1
- 25
Creative Medical Technology Holdings Inc.
Creative Medical Technology Holdings, Inc., a biotechnology company, focuses on immunology, urology, orthopedics, and neurology using adult stem cell treatments. The company offers CaverStem for the treatment of erectile dysfunction; FemCelz for the treatment of loss of genital sensitivity and dryness; StemSpine for the treatment of chronic lower back pain; Amniostem for the treatment of strokes, radiation, toxicity, and glioma; ImmCelz for the treatment of stroke patients; and OvaStem for treatment of female infertility. Creative Medical Technology Holdings, Inc. was incorporated in 1998 and is based in Phoenix, Arizona.
S&P Global Inc.
S&P Global Inc., together with its subsidiaries, provides ratings, benchmarks, analytics, and data to the capital and commodity markets worldwide. The company operates through four segments: S&P Global Ratings (Ratings), S&P Global Market Intelligence (Market Intelligence), S&P Global Platts (Platts), and S&P Dow Jones Indices (Indices). The Ratings segment offers credit ratings, research, and analytics to investors, corporations, governments, municipalities, commercial and investment banks, insurance companies, asset managers, and other debt issuers. The Market Intelligence segment provides multi-asset-class data, research, and analytical capabilities that integrate cross-asset analytics and desktop services to investment managers, investment banks, private equity firms, insurance companies, commercial banks, corporations, professional services firms, government agencies, and regulators. The Platts segment offers essential price data, analytics, and industry insights for the commodity and energy markets. It serves producers, traders, and intermediaries within the energy, petrochemicals, metals, and agriculture markets. The Indices segment provides index that maintains various valuation and index benchmarks for investment advisors, wealth managers, and institutional investors. The company also offers analytics, artificial intelligence, machine learning, and data visualization systems to Wall Street's premier global banks and investment institutions, as well as the National Security community; subscription and custom reports on bank deposits, loans, fees, and other product data to the financial services industry; and insights on global supply chains. The company was formerly known as McGraw Hill Financial, Inc. and changed its name to S&P Global Inc. in April 2016. S&P Global Inc. was founded in 1860 and is headquartered in New York, New York.
Latest CELZ
- SEC Form S-3 filed by Creative Medical Technology Holdings Inc.
- SEC Form DEF 14A filed by Creative Medical Technology Holdings Inc.
- Creative Medical Technology Holdings Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Leadership Update, Financial Statements and Exhibits
- SEC Form PRE 14A filed by Creative Medical Technology Holdings Inc.
- Creative Medical Technology Holdings Issues Mid-Year Update
- Creative Medical Technology Holdings Announces Agreements for Exercise of Warrants for $4.5 Million Gross Proceeds
- SEC Form RW filed by Creative Medical Technology Holdings Inc.
- Amendment: SEC Form S-1/A filed by Creative Medical Technology Holdings Inc.
- SEC Form S-1 filed by Creative Medical Technology Holdings Inc.
- Creative Medical Technology Holdings Expands ADAPT Trial Under New FDA Clearance and Rapidly Advances Toward Phase 3 Planning for Olastrocel in Chronic Lower Back Pain
Latest SPGI
- S&P Global Market Intelligence Partners with Farsight to Launch AI-powered Financial Workflow Capability for Capital IQ Pro
- S&P Dow Jones Indices and Pantera Capital Launch New Index for Digital Assets
- S&P Global Launches Adaptive Retrieval, Giving Customers a New Way to Access Data Across AI and Agentic Workflows
- Krystal Biotech Set to Join S&P MidCap 400; Tutor Perini and V2X to Join S&P SmallCap 600
- S&P DOW JONES INDICES AND MSCI ANNOUNCE CONSULTATION ON POTENTIAL CHANGES TO THE GLOBAL INDUSTRY CLASSIFICATION STANDARD (GICS®)
- Molina Healthcare Set to Join S&P MidCap 400 and Construction Partners to Join S&P SmallCap 600
- Liquefied Natural Gas Set to Become United States' 2nd Largest Net Export Industry within Five Years, S&P Global Energy Study Finds
- S&P Global Market Intelligence Launches ETF Intelligence
- BrightSpring Health Services Set to Join S&P MidCap 400 and Karman Holdings to Join S&P SmallCap 600
- Solaris Energy Infrastructure Set to Join S&P SmallCap 600